Patents by Inventor Martin J. Thoolen

Martin J. Thoolen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES
    Publication number: 20220133648
    Abstract: The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
    Type: Application
    Filed: August 11, 2021
    Publication date: May 5, 2022
    Inventors: Orion D. Jankowski, Kieron E. Wesson, Katsuyuki Murase, Guy M. Miller, Martin J. Thoolen
  • TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES
    Publication number: 20190216749
    Abstract: The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
    Type: Application
    Filed: December 7, 2018
    Publication date: July 18, 2019
    Inventors: Guy M. Miller, Martin J. Thoolen
  • TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES
    Publication number: 20170246124
    Abstract: The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
    Type: Application
    Filed: October 7, 2016
    Publication date: August 31, 2017
    Inventors: Guy M. MILLER, Martin J. THOOLEN
  • TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES
    Publication number: 20140343166
    Abstract: The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
    Type: Application
    Filed: December 2, 2013
    Publication date: November 20, 2014
    Inventors: Guy M. MILLER, Martin J. THOOLEN
  • METHODS FOR IMPROVING BLOOD GLUCOSE CONTROL
    Publication number: 20120295985
    Abstract: The present invention is concerned with a method for improving blood glucose control or for preventing or treating a condition requiring increasing insulin sensitivity or reducing insulin resistance in a subject in need of such control which comprises administering to the subject a composition comprising a therapeutically effective amount of one or more quinones of Formula I.
    Type: Application
    Filed: November 18, 2011
    Publication date: November 22, 2012
    Inventors: Guy M. Miller, William D. Shrader, Martin J. Thoolen
  • TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES
    Publication number: 20110172312
    Abstract: The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
    Type: Application
    Filed: December 30, 2010
    Publication date: July 14, 2011
    Inventors: Guy M. MILLER, Martin J. Thoolen
  • Azapropazone prevention of post-ischemic tissue damage
    Patent number: 4668676
    Abstract: Azapropazone can be used to prevent post-ischemic tissue damage in mammals.
    Type: Grant
    Filed: July 15, 1986
    Date of Patent: May 26, 1987
    Assignee: E.I. Du Pont de Nemours and Company
    Inventors: George A. Boswell, William M. Mackin, Martin J. Thoolen